1.Comparison of capabilities of survival, proliferation and expansion between CD34+CD59+ cells from patients with PNH and CD34+ cells from normal control.
Juan XIAO ; Yong-ji WU ; Zhi-nan ZHANG ; Zhao-jiang LU ; Shi-ping CHEN ; Hong-yan DONG
Acta Academiae Medicinae Sinicae 2002;24(5):495-500
OBJECTIVETo explore in vitro expansion of CD34+CD59+ cells from patients with PNH, and compare the capabilities of survival, proliferation and expansion between CD34+CD59+ cells from patients with PNH and CD34+ cells from normal control.
METHODSCD34+CD59+ cells from patients with PNH and CD34+ cells from normal control were selected from the bone marrow mononuclear cells by means of two-step sorting method with immunomagnetic microbead-flow cytometry, then underwent in vitro expansion for two weeks and semi-solid culture in vitro before and after expansion.
RESULTS(1) CD34+CD59+ cells from patients with PNH can be expanded effectively in vitro, and the biggest expansion of CD34+CD59+ cells was about 23.49 fold on the 7th day. (2) There were some similar characteristics between CD34+CD59+ cells from patients with PNH and CD34+ cells from normal control, such as: the best combination of hematopoietic factors for in vitro expansion was SCF+ IL-3 + IL-6 + FL + Tpo + Epo, and the seventh day was the most suitable in course of 4-14 days for in vitro expansion, and after in vitro expansion, the cells remained CD59 positive and strong capability of performing colony-forming. (3) CD34+ cells from normal control had better proliferation, expansion and stronger potential to survive than CD34+CD59+ cells from patients with PNH.
CONCLUSIONS(1) In vitro expansion of CD34+CD59+ cells from patients with PNH can be performed. The present study showed the possibility of performing ABMT or APBSCT clinically for patients with PNH. (2) There were some similar characteristics between CD34+CD59+ cells from patients with PNH and CD34+ cells from normal control, but the latter had better proliferation, expansion and stronger potential to survive than the former. CD34+CD59+ cells from patients with PNH were not completely normal cells.
Antigens, CD34 ; analysis ; Bone Marrow Cells ; cytology ; immunology ; CD59 Antigens ; analysis ; Cell Differentiation ; Cell Division ; Cell Survival ; Cells, Cultured ; Hemoglobinuria, Paroxysmal ; immunology ; pathology ; Humans ; Immunophenotyping
2.CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
Yoo Hong MIN ; Seung Tae LEE ; Dong Won MIN ; Tai Seung KIM ; Chan Hee LEE ; Byung Kwon LEE ; Jee Sook HAHN ; Yun Woong KO
Yonsei Medical Journal 1995;36(1):1-8
Although it has been shown that the percentage of bone marrow blasts in myelodysplastic syndrome (MDS) constitute the only independent determinant of survival and progression to acute leukemia, the great variability in survival among patients with MDS of similar percentage of blasts has prompted us to investigate new objective, independent prognostic parameters for the selection of high-risk patients. It was suggested that CD34 antigen expression adversely affected the prognosis of acute myelogenous leukemia. However, no study has been published so far on clinical and prognostic significance of CD34 antigen expression in MDS. Bone marrow biopsies from 58 patients diagnosed as primary MDS were studied using QBEND/10, a monoclonal antibody which recognized the human progenitor CD34 antigen on routine aldehyde-fixed, paraffin-embedded samples. The high percentage of CD34-positive cells (above 3% of total bone marrow nucleated cells) was predominantly observed in cases with RAEB-T, CMML, and to a lesser degree in RAEB. But neither age, hemograms, bone marrow findings including percentage of blasts, ALIP, nor leukemic transformation correlated with the percentage of CD34-positive cells. The median actuarial survival time in the high positive group was significantly shorter (12.0 months) than that of the low group (30.0 months; p = 0.028). The high CD34 aggregate (> or = 3) was selectively found in cases with RAEB, RAEB-T, and CMML. The percentage of bone marrow blasts (p = 0.007) and ALIP (p = 0.030) significantly correlated with number of CD34 aggregates.
Adult
;
Aged
;
Antigens, CD/*analysis
;
Antigens, CD34
;
Biopsy
;
Bone Marrow/*immunology/*pathology
;
Human
;
Immunohistochemistry/methods
;
Middle Age
;
Myelodysplastic Syndromes/*immunology/*pathology
;
Staining and Labeling
;
Tumor Markers, Biological
3.Isolation and enrichment of hematopoietic stem/progenitor cells from human placenta tissue.
Tao ZHANG ; Dai-Xiong CHEN ; Ning FANG ; Zu-Lin LIU ; Ying QI ; Jin-Wei LIU
Journal of Experimental Hematology 2006;14(5):955-958
The aim of this study was to establish the standard protocols for isolating and enriching hematopoietic stem/progenitor cells (HSPC) from human placenta tissue (PT). Single-cell suspension from of human PT was prepared by mechanical method combined with collagenase digestion. Mononucleated cells (MNC) derived from PT were separated by hydroxyethyl starch (6% HES), then the three cell subsets of different immunophenotypes (CD34(-), CD34(+)CD38(-), CD34(+)CD38(+)) contained in MNC were isolated by Magnetic Activated Cell Sorting (MACS). The cell immunophenotype of each sorting steps was analyzed by flow cytometer (FCM). The cell enrichment and recovery rate of each sorting step were calculated. The results showed that MNC could be harvested up to (12.30 +/- 3.51) x 10(8) from a single-cell suspension of human PT by mechanical method and collagenase digestion, no significant difference existed as compared with umbilical cord blood (UCB) initial sample [(8.86 +/- 5.38) x 10(8)], but the percentage of CD34(+) cells in MNC of human PT was (3.93 +/- 2.31)%, much higher than that in UCB [(0.44 +/- 0.29)%] (P < 0.001). recovery rate of MNC and CD34(+) cells from PT after separation with 6% HES were (45.3 +/- 11.7)% and (51.1 +/- 9.8)%, respectively. After MNC being sorted by MACS, the enrichment and recovery rate of CD34(+) cells in CD34(+) group were (73.4 +/- 14.1)% and (52.7 +/- 11.7)% respectively. It is concluded that the protocols established here for isolating and enriching hematopoietic stem/progenitor cells from human placenta can acquire HSPC with high abundance, enrichment and viability and may be a useful reference of isolating methods for future related study.
Antigens, CD34
;
analysis
;
Cell Proliferation
;
Cell Separation
;
methods
;
Hematopoietic Stem Cells
;
cytology
;
immunology
;
Humans
;
Immunophenotyping
;
Placenta
;
cytology
4.Study of biological characteristics of the CD(34)(+) CD(59)(+) and CD(34)(+) CD(59)(-) cells from PNH patients' bone marrow.
Juan XIAO ; Yong-ji WU ; Zhi-nan ZHANG ; Zhao-jiang LU ; Shi-ping CHEN ; Hong-yan DONG
Chinese Journal of Hematology 2003;24(4):169-173
OBJECTIVETo explore the characteristics of CD(34)(+) CD(59)(+) cells from paroxysmal nocturnal hemoglobinuria(PNH) patients' bone marrow and the possible reasons of hematopoietic clonal dominance of PNH clones.
METHODSCD(34)(+) CD(59)(+) and CD(34)(+) CD(59)(-) cells from PNH patients and CD(34)(+) cells from normal control were selected from the bone marrow mononuclear cells by means of immunomagnetic microbead-flow cytometry two step sorting method undergone ex vivo expansion in liquid culture for two weeks and performed semisolid cultures before and after expansion.
RESULTS(1) Cultivation for seven days was the optimum for ex vivo expansion of PNH CD(34)(+) CD(59)(+) cells and normal CD(34)(+) cells, both cell populations remained CD(59) positive after expansion. (2) Normal CD(34)(+) cells had higher capacities of proliferation and expansion, and stronger potential to survival than that of both PNH CD(34)(+) CD(59)(+) and PHN CD(34)(+) CD(59)(-) cells. (3) In terms of semisolid culture, there was no significant difference in the yields of CFU formation between CD(34)(+) CD(59)(+) and CD(34)(+) CD(59)(-) cells. (4) In liquid culture with combinations of hematopoietic factors SCF + IL-3 + IL-6 + FL + Tpo or SCF + IL-3 + IL-6 + FL + Tpo + Epo, there was no significant difference in the capabilities of survival, proliferation and expansion between CD(34)(+) CD(59)(+) and CD(34)(+) CD(59)(-) cells; but with combination of SCF + IL-3 + IL-6 + FL + Tpo + Epo + GM-CSF, CD(34)(+) CD(59)(-) cells had better proliferation and expansion capacities and stronger potential to survival than that of CD(34)(+) CD(59)(+) cells.
CONCLUSIONS(1) Normal CD(34)(+) cells had better proliferation, expansion capacities and stronger potential to survival than that of PNH CD(34)(+) CD(59)(+)cells. (2) In semisolid and liquid culture with hematopoietic factor combinations, there was no significant difference in the capabilities of survival, proliferation and expansion between CD(34)(+) CD(59)(+) and CD(34)(+) CD(59)(-) cells. It was suggested that CD(34)(+) CD(59)(-) cells had no clonal hemotopoiesis dominance. GM-CSF might be one of the reasons for PHN clones to possess clonal hematopoiesis dominance.
Antigens, CD34 ; analysis ; Bone Marrow Cells ; cytology ; immunology ; CD59 Antigens ; analysis ; Cell Division ; Cell Survival ; Cells, Cultured ; Flow Cytometry ; Hemoglobinuria, Paroxysmal ; pathology ; physiopathology ; Humans
5.The effects of sera from patients with paroxysmal nocturnal hematoglobinuria on the growth of CD34(+) cells.
Bing HAN ; Yong-Ji WU ; Zhi-Nan ZHANG
Journal of Experimental Hematology 2002;10(1):47-51
To investigate the effects of sera on the growth of single CD34(+) cells from patients with paroxysmal nocturnal hematoglobinuria (PNH), sera from both PNH patients and normal individuals were added separately to the single cell culture system and semi-solid colony formation system. The growth of the normal CD34(+) and PNH CD34(+) CD59(+) and CD34(+) CD59(-) cells was evaluated. No growth difference was found for growth of the normal CD34(+) and PNH CD34(+) CD59(+) cells when PNH or normal sera were added to the culture media in either single cell culture or colony formation culture. While no difference was detected for single PNH CD34(+) CD59(-) cells growth when PNH or normal sera were added, more colonies were observed in semi-solid culture with PNH sera. A conclusion was reached that compared with those from normal controls, the sera from PNH patients had no significant influence on single hematopoietic stem/progenitor cells derived from normal subjects and from PNH patients, but the PNH sera might promote the colony formation of the CD34(+) CD59(+) cells in semi-solid culture
Antigens, CD34
;
analysis
;
Blood Proteins
;
pharmacology
;
CD59 Antigens
;
analysis
;
Cell Division
;
drug effects
;
Cells, Cultured
;
Hematopoietic Stem Cells
;
drug effects
;
pathology
;
Hemoglobinuria, Paroxysmal
;
immunology
;
pathology
;
Humans
6.A Case of Primary Hepatic Epithelioid Hemangioendothelioma Mimicking Metastatic Carcinoma.
Sang Gi KIM ; Min Kyu JUNG ; Seong Woo JEON ; Chang Min CHO ; Won Young TAK ; Young Oh KWEON ; Sung Kook KIM ; Yong Hwan CHOI
The Korean Journal of Gastroenterology 2007;50(1):61-65
Epithelioid hemangioendothelioma is a rare vascular origin tumor which usually occurs in soft tissues, liver, and lung. It usually affects adult women and presents as multiple hepatic nodules with mainly peripheral distribution. It is difficult to diagnose and treat because of non-specific clinical manifestations and findings on the imaging study. Moreover, pathological misdiagnosis is common. We report a case of this rare tumor that was detected incidentally. Final diagnosis was based on histological evidence. A 52-years old man suffered from right upper quadrant abdominal pain for 3 months, and was initially misdiagnosed as a metastatic carcinoma. Physical examination revealed superior cervical lymphadenopathy with mild hepatomegaly. Finally, hepatic epithelioid hemangioendothelioma was diagnosed on the basis of positive immunohistochemical staining for factor VIII, CD34, and VEGF. Our case highlights the importance of a histological diagnosis to avoid misdiagnosis.
Antigens, CD34/analysis/immunology
;
Carcinoma/secondary
;
Diagnosis, Differential
;
Factor VIII/analysis/immunology
;
Hemangioendothelioma, Epithelioid/*diagnosis/pathology
;
Humans
;
Immunohistochemistry
;
Liver Neoplasms/*diagnosis/pathology
;
Male
;
Middle Aged
;
Positron-Emission Tomography
7.Proliferation and apoptosis in vitro of umbilical cord blood CD34+CD38- hematopoietic early progenitor cells.
Hong TIAN ; Shi-Ang HUANG ; Fei-Li GONG ; Jin-E ZHENG ; Yan-Li HE ; Jing YANG ; Zhong CHEN
Journal of Experimental Hematology 2005;13(2):229-234
To cultivate CD34(+)CD38(-) cells isolated from umbilical cord blood of healthy puerperal women over a longer-period of time for observation of cell division, proliferation, apoptosis, and effects of stem cell factor on the growth of CD34(+)CD38(-) cells, with flow cytometry, CD34(+)CD38(-) cells were isolated from umbilical cord blood of 10 healthy puerperal women and cultivated in stem cell media with supplement of IL-3, IL-6, GM-CSF, EPO, IGF-1 and SCF 6 kinds cell growth stimulating factors for six months. The cell growth curves were established. The effects of stem cell factor on the growth of CD34(+)CD38(-) cells and cell apoptosis were investigated with the single cell gel electrophoresis technique and flow cytometry method, respectively. The results showed that CD34(+)CD38(-) cells isolated from umbilical cord blood were capable of proliferating after being cultivated in vitro over a longer-period of time with no evidence of the presence of excessive apoptosis. In conclusion, under appropriate culture conditions, CD34(+)CD38(-) hematopoietic early progenitor cells from umbilical cord blood can serve as a resource providing a large amount of primitive cells for transplantation therapy after a longer period of cultivation and proliferation in vitro.
ADP-ribosyl Cyclase 1
;
analysis
;
Adult
;
Antigens, CD34
;
analysis
;
Apoptosis
;
Cell Proliferation
;
Cells, Cultured
;
Female
;
Fetal Blood
;
cytology
;
immunology
;
Flow Cytometry
;
Hematopoietic Stem Cells
;
cytology
;
immunology
;
Humans
8.Ex vivo expansion of CD34(+) CD59(+) cells from bone marrow of paroxysmal nocturnal hemoglobinuria patients.
Juan XIAO ; Yongji WU ; Zhinan ZHANG ; Zhaojiang LU ; Xuan WANG
Chinese Journal of Hematology 2002;23(11):568-570
OBJECTIVETo study the separation, purification and ex vivo expansion of CD(34)(+) CD(59)(+) cells from patients with paroxysmal nocturnal hemoglobinuria (PNH), and explore the new treatment for the PNH patients.
METHODSCD(34)(+) CD(59)(+) cells were selected from the bone marrow mononuclear cells of PNH patients by means of immunomagnetic microbead-flow cytometry two step sorting method, followed by ex vivo expansion of the cells with combination of hematopoietic factors for two weeks.
RESULTSThe best combination for the ex vivo expansion was SCF + IL-3 + IL-6 + FL + Tpo + Epo, and the seventh day was the most suitable time for the best harvest when the CD(34)(+) CD(59)(+) cells were 22.42 +/- 3.73 fold expanded. After ex vivo expansion, the cells remained CD(59) positive and potent capacity of colony formation, but their potentialities to multilineage differentiation were decreased.
CONCLUSIONThe present study shows that ex vivo expansion of CD(34)(+) CD(59)(+) cells from PNH patients might promise the possibility of performing ABMT or APBSCT clinincally for the patients.
Antigens, CD34 ; analysis ; Bone Marrow Cells ; cytology ; immunology ; CD59 Antigens ; analysis ; Cell Differentiation ; immunology ; Cell Division ; immunology ; Cell Lineage ; Flow Cytometry ; Hemoglobinuria, Paroxysmal ; blood ; immunology ; Humans ; Immunophenotyping ; Time Factors
9.Study on the immunophenotypes of bone marrow cells from patients with myelodysplastic syndromes and its clinical implications.
Jian-Ying WANG ; Xiao-Ming LI ; Fa-Ju LI ; Xin-Gui CHEN
Journal of Experimental Hematology 2002;10(2):173-174
The phenotypes of the bone marrow cells in various subtypes of myelodysplastic syndromes (MDS) and its clinical implication were explored. The antigen expression of a panel of antigens expressed in marrow cells from 30 patients with subtypes of MDS was assayed by alkaline phosphatase anti-alkaline phosphatase method. The results showed that the expression of myeloid antigens appeared abnormality, CD13 and CD33, found on granulocyte and macrophage precursors, increased, and CD15 decreased. There were no significant changes for monocytic antigen CD14 and lymphoid antigens CD7 and CD10. CD34 was increased in RAEB/RAEB-t and was not increased in RA/RAS patients. CD71, expressed by erythroblast and proliferative cells, was higher in all subtypes of MDS than that in control group. It is suggested that the bone marrow cells from MDS patients showed abnormality of more than two series of immunophenotypes, detection of immunophenotype in MDS cells might be contributed to the diagnosis and predicting prognosis.
Adult
;
Aged
;
Antigens, CD
;
analysis
;
Antigens, CD34
;
analysis
;
Antigens, CD7
;
analysis
;
Antigens, Differentiation, B-Lymphocyte
;
analysis
;
Antigens, Differentiation, Myelomonocytic
;
analysis
;
Bone Marrow Cells
;
immunology
;
CD13 Antigens
;
analysis
;
Female
;
Humans
;
Immunophenotyping
;
Lewis X Antigen
;
analysis
;
Lipopolysaccharide Receptors
;
analysis
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
immunology
;
pathology
;
Neprilysin
;
analysis
;
Receptors, Transferrin
;
Sialic Acid Binding Ig-like Lectin 3
10.Immunophenotypic features of bcr/abl fusion transcript-positive B-lineage acute lymphoblast leukemia.
Jin-Lan LI ; Yan-Rong LIU ; Ya-Zhen QIN ; Yan CHANG ; Jia-Yu FU ; Hui WANG ; Guo-Rui RUAN ; Shan-Shan CHEN
Journal of Experimental Hematology 2003;11(2):142-145
To investigate the biological features of leukemic cells in bcr/abl fusion transcript-positive B-lineage acute lymphoblastic leukemia (B-ALL), 3- or 4-color flow cytometry with directly conjugated monoclonal antibodies was used to detect the immunophenotype of the cells in 26 patients with bcr/able-positive B-ALL and 32 patients with bcr/abl-negative B-ALL. bcr/abl fusion transcript was detected by RT-PCR. Immunoglobulin heavy chain (IgH) gene rearrangement was detected by PCR. The results showed that all of the B-ALL patients were positive for CD19. There was significant difference in expression of CD34 (96.2% vs 65.6%), CD10 (96.2% vs 71.8%) and CD38 (43.8% vs 95.4%) between bcr/abl-positive and -negative groups. In bcr/abl-positive B-ALL group, the co-expression rates of CD10(+)/CD19(+)/CD34(+), CD10(+)/CD34(+)/HLA-DR(+) and CD10(+)/CD34(+)/CD38(-) were 92.3% (24/26), 73.1% (19/26) and 56.2% (9/16), respectively. In bcr/abl-negative group, co-expression of CD10(+)/CD19(+)/CD34(+) and CD10(+)/CD34(+)/HLA-DR(+) were 43.8% (14/32) and 37.5% (12/32), respectively, there were significant differences (P < 0.05) between bcr/abl-positive and -negative groups, but none of the cases co-expressed CD10(+)/CD34(+)/CD38(-). The detection rate of monoclonal IgH gene rearrangement (58.8%, 10/17) was lower in bcr/abl-positive group than that (85.7%, 12/14) in bcr/able-negative group. It is concluded that the expression rates of CD34 and CD10 are higher, and CD38 and IgH gene rearrangement are lower in bcr/abl-positive B-ALL cases, CD10(+)/CD34(+)/CD38(-) is a unique feature of immunophenotype, and this phenotype of leukemia cells is closer to that of early B-lineage progenitor cells.
Adolescent
;
Adult
;
Aged
;
Antigens, CD19
;
analysis
;
Antigens, CD34
;
analysis
;
Burkitt Lymphoma
;
immunology
;
Child
;
Female
;
Flow Cytometry
;
Fusion Proteins, bcr-abl
;
genetics
;
Humans
;
Immunophenotyping
;
Leukocyte Common Antigens
;
analysis
;
Male
;
Middle Aged
;
Neprilysin
;
analysis
;
Polymerase Chain Reaction
;
RNA, Messenger
;
analysis